Should we Consider Lipoprotein (a) in Cardiovascular Disease Risk Assessment in Patients with Familial

Panagiotis Anagnostis1,2, Pavlos Siolos2, Dimitrios Krikidis3

  • 1Unit of Reproductive Endocrinology, 1st Department of Obstetrics and Gynaecology, Medical School, Aristotle University of Thessaloniki, Greece.

Insights

Familial hypercholesterolaemia (FH) patients have elevated Lipoprotein (a) [Lp(a)] levels, a key factor in cardiovascular disease (CVD) risk. Understanding Lp(a) is crucial for managing FH and preventing CVD.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Lipidology

Background:

  • Familial hypercholesterolaemia (FH) is a genetic lipid disorder affecting 1 in 200-500 people.
  • FH significantly increases Cardiovascular Disease (CVD) risk but is often underdiagnosed and undertreated.
  • Lipoprotein (a) [Lp(a)] is an LDL-like molecule with an additional apolipoprotein (a).

Purpose of the Study:

  • To review and discuss existing data on Lp(a) in FH patients.
  • To evaluate the role of Lp(a) in augmenting CVD risk within the FH population.

Main Methods:

  • A comprehensive literature search was conducted.
  • Studies focused on evaluating the cardiovascular effects of Lp(a) in FH patients.

Main Results:

  • Lp(a) is an established independent risk factor for CVD, particularly coronary artery disease (CAD).
  • Elevated Lp(a) concentrations are observed in most adults and children with FH.
  • An independent association exists between Lp(a) and CVD (primarily CAD) risk in FH patients.

Conclusions:

  • Therapeutic agents like niacin, oestrogens, tibolone, and PCSK9 inhibitors can reduce Lp(a) by 25-30%.
  • The clinical benefit of Lp(a) reduction with these therapies requires further establishment.
Abstract

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
573
Protein Families02:47

Protein Families

Protein families are groups of homologous proteins; that is, they have similarities in amino acid sequences and three-dimensional structures. Protein families usually occur because of gene duplication, where an additional copy of a gene is inserted into the genome of an organism.   Mutations that change the amino acids but still allow the protein to be properly synthesized, will lead to new protein family members.   If these new proteins contain similar amino acids in key...
16.9K
Protein Families02:47

Protein Families

4.5K
Gene Families01:57

Gene Families

Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
9.9K
Gene Families01:57

Gene Families

3.8K
Assessment of the Cardiovascular System II: Inspection01:29

Assessment of the Cardiovascular System II: Inspection

Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
853